VIRTUALMAN is Taiwan's leading AI-native drug discovery company, specializing in reviving abandoned preclinical drug assets through ADMET/PK optimization, lead compound generation, and proprietary synthesizability prediction. 

At the core of our approach is the "New Drug Revival Engine" — a business model that re-optimizes high-potential assets abandoned due to ADMET/PK issues and transforms them into licensable drug candidates. This model has been validated through collaboration with DCB (Development Center for Biotechnology). 

Backed by the National Development Fund and ITIC, and selected for the NVIDIA Inception Program, our vision is to become the Pipeline Creation Engine for pharmaceutical companies worldwide.

VIRTUALMAN

This department focuses on financial strategies and business growth initiatives.

People (2)

Jobs (0)

Other teams